Categories
Article Boron Compounds Boron Determination Chemistry In-vitro Studies In-vivo Studies Pharmacokinetics Toxicity Year 2023

Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy

Journal of Radiation Research, 2023

Categories
Article Mixed Therapies Toxicity Year 2009

Boron neutron capture therapy for newly diagnosed glioblastoma

Radiotherapy and Oncology, 2009

Categories
Article Case Report Toxicity Year 2005

Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages

Journal of Neurosurgery, 2005

Categories
Article Case Report Toxicity Year 2007

Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis

Oncology Reports, 2007

Categories
Article Reterospective Study Toxicity Year 2014

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer

Journal of Radiation Research, 2014

Categories
Article Case Report Toxicity Year 2014

Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck

International Journal of Clinical Oncology, 2014

Categories
Article Mixed Therapies (BNCT + Other Therapies) Recurrences Toxicity Year 2022

Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma

Japanese Journal of Clinical Oncology, 2022

Categories
Article Case Report Medicine Recurrences Toxicity Year 2021

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report

Neuro-Oncology Advances, 2021

Categories
Article Clinical trials Phase II Studies Toxicity Year 2022

Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study

Journal of Radiation Research, 2022

Categories
Article Clinical trials Phase II Studies Toxicity Year 2021

Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study

Neurooncology Advances, 2021